Analyst Report: HONA

1. EXECUTIVE SUMMARY

Honeywell Aerospace fell 9.60% to $160.04 on Thursday October 29, 2026, the session after it reported third-quarter results that beat estimates on adjusted EPS and revenue and raised the 2026 adjusted EPS range. The sell-off follows a 5.44% rise on October 28, which happened before the release, so the stock gave back that gain and more. Profit quality drew the criticism: TIKR pointed out that adjusted EBIT rose about 1% including roughly $50m of one-time tariff refunds, that Engines and Power Systems segment profit fell 16%, and that the EPS increase in guidance came mostly from lower below-the-line expenses while the adjusted EBIT midpoint stayed at $4.4bn. Peers rose between 1.73% and 5.51% over the same period, so the fall is specific to the company. Supply constraints remain the main operating issue, with backlog up 12% to $19.3bn. The brief does not say which single factor mattered most to sellers, so the weighting of these points is inference.

2. THE CATALYST

Honeywell released Q3 results, a guidance update and its first dividend after the close on October 28 (Yahoo Finance press release; Trefis). The stock had closed that day at $177.03, up 5.44% on volume of 5,342,400, so the run-up preceded the release. The reaction came in the October 29 session, which opened at $166.18, traded as low as $153.00 and closed at $160.04 on volume of 7,433,700.

Motley Fool framed the day as a beat followed by a sell-off, and described the beat as strong. TIKR argued it was thinner than the headline figures suggest. Reports of the after-hours reaction disagree: Benzinga reported a much smaller drop than the close, and an Investing.com headline cited about 3%.

3. COMPANY PROFILE

Honeywell Aerospace Inc. (Industrials, Aerospace & Defense) supplies aircraft components, avionics, engines and systems to airframe makers, commercial airlines, military and defense customers, business aviation and space markets. Its peer group in the facts includes Boeing, GE, RTX, Lockheed Martin, Howmet and Northrop Grumman. The market capitalisation is $50.73bn.

The August quarter set the backdrop. On August 6, Q2 results and a guidance cut drove a close about 23% lower, with organic sales growth moved to 4% to 5% from 7% to 9% and supply constraints cited as the cause (Morningstar/SueWallSt; Quartz). The stock gained 6.0% on August 19 (Trefis). A class action covers the period from June 29 to September 1, 2026 (Kirby McInerney).

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The headline beat was real, but the quality of earnings was weaker. Reported EBIT growth of about 1% included the tariff refunds, and the guidance raise came from items below operating profit. Operating guidance did not change. Inference: after a 5.44% pre-release rise, the stock had priced in more than the report delivered, which accounts for a drop of this size.

Supply. Management said backlog grew 12% to $19.3bn and would have grown more than 8% faster had supply kept pace, with bearings the hardest category this year (TIKR). A second-source bearing supplier should clear past-due orders by early 2027, and a third comes online in Q2 2027. About 70 suppliers are on performance watch (MarketBeat). Trailing 12-month defense orders rose 18%, while international sales fell in the quarter (Benzinga transcript). Management also said margins may not expand in a straight line as supply-chain spending moves into operating expense and capex (TradingView/MarketBeat). A few deals expected later in the year closed in Q3 and added about one point of growth, which suggests some demand was pulled forward.

Peers. Peers rose over the same period (HWM +5.51%, GE +3.96%, BA +3.30%, LMT +2.20%, RTX +1.82%, NOC +1.73%) while the S&P 500 fell 0.30%. GE is buying a castings maker to ease its own shortage and reported LEAP deliveries up only 5% in Q3, and RBC Bearings' aerospace and defense sales rose 37% (TIKR). Supply tightness affects the whole group, and demand is not the problem.

Analysts. JPMorgan cut its target to $210 from $235 and kept Neutral (MarketBeat). BNP Paribas raised its target to $175 from $160 (MarketScreener). The mean target across 17 analysts was about $198.87 (MarketScreener), roughly 24% above the close. A reported BMO downgrade is undated and unverified, and is left out of the analysis.

Bull case. Backlog and defense orders are growing, free cash flow guidance is higher, supply should improve through 2027, and the forward P/E of 18.1 sits far below the trailing 48.8.

Bear case. Operating profit is flat, the Engines and Power Systems segment is shrinking, margins will not expand steadily, and supply problems have already produced one guidance cut in August.

5. TECHNICAL SNAPSHOT

The close of $160.04 sits just below the 50-day average of $160.23 and 7.2% above the 52-week low of $149.19 set on September 10, and far under the 52-week high of $297.50 from June 16. The 200-day average is not available. Volume of 7,433,700 was 2.15x the 50-session average, so the sell-off drew broad participation. The nearest support is the October 20 close of $159.90, only slightly below the latest close, with the September low beneath it. The nearest resistance is the October 23 close of $163.31, followed by $168.64 from October 26.

6. RISK FACTORS

• Further supply failures, particularly in bearings, castings and forgings, could cut output again after the August guidance cut.
• Tariff refunds are one-time, so the EBIT comparison is harder in later quarters.
• The Engines and Power Systems decline of 16% may continue.
• The class action has a lead-plaintiff motion deadline of November 23, 2026.
• The date of the fiscal Q4 2026 report was not found in the sources.
• The first quarterly dividend of $0.40 is payable in December.
• The Tempe, Arizona plant, about $500m, is not due until late 2028.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks): The stock trades at its 50-day average on elevated volume. The August episode saw a 6.0% rebound about two weeks after the drop, which offers a precedent, though the circumstances differ. Holding $159.90 would keep the range between that level and $163.31 intact, and a close under $159.90 puts the $149.19 low in view. The November 23 deadline falls outside this window.

Medium term (1-3 months): Evidence of bearing deliveries recovering and the backlog converting to sales will drive the shares, as will any improvement in operating profit beyond the tariff refunds. The next report is the main test, and its date is unconfirmed.

Long term: The thesis rests on demand, with backlog up 12% and defense orders up 18%. Execution on supply is the open question. Management's own timeline places relief in early 2027 and Q2 2027, so the thesis is unchanged but its timing has moved out. This is analysis only and not personal financial advice.